-
1 Comment
Shanghai Pharmaceuticals Holding Co., Ltd is currently in a long term uptrend where the price is trading 10.9% above its 200 day moving average.
From a valuation standpoint, the stock is 99.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.2.
Shanghai Pharmaceuticals Holding Co., Ltd's total revenue sank by 45.1% to $52B since the same quarter in the previous year.
Its net income has dropped by 50.2% to $894M since the same quarter in the previous year.
Finally, its free cash flow grew by 158.3% to $870M since the same quarter in the previous year.
Based on the above factors, Shanghai Pharmaceuticals Holding Co., Ltd gets an overall score of 3/5.
| Exchange | HK |
|---|---|
| CurrencyCode | HKD |
| ISIN | CNE1000012B3 |
| Sector | Healthcare |
| Industry | Medical Distribution |
| Dividend Yield | 4.8% |
|---|---|
| PE Ratio | 8.7 |
| Target Price | 13.5374 |
| Beta | 0.45 |
| Market Cap | 65B |
Shanghai Pharmaceuticals Holding Co., Ltd. engages research, development, manufacture, distribution, and retailing of pharmaceutical and healthcare products in China and internationally. The company operates through four segments: Production, Distribution, Retail, and Others. It offers chemicals and biochemicals, Chinese medicines, healthcare products, and medical devices in various therapeutic areas, including digestive system, immune metabolism, motor neuron disease, endocrinology, cardiovascular, psychoneurotic, neoplasm, autoimmunity, systemic anti-infection, mental nerve, anti-tumor, oncology, respiratory system, nervous system, auto-immunity, hypertension, neuromyelitis, diabetes, anticholinesterase, polypeptide hormones uterine tonic, antihistamine, anti-inflammatory, anesthetic, immunomodulatory, antiviral, reflux esophagitis, analgesics, weight management, malignant peritoneal effusion, ulcerative colitis, myasthenia gravis, burn injury, anticoagulant, anti-epileptic, anticonvulsant, Alzheimer's, and inflammatory bowel diseases. The company also engages in the provision of pharmaceutical distribution, warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, it engages in the operation of a network of retail pharmacy stores. The company was incorporated in 1994 and is headquartered in Shanghai, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 2607.HK using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
